{
    "Trade/Device Name(s)": [
        "BioScanner Plus Glucose Test System",
        "PTS PANELS Chol+Glu Test Panel System",
        "PTS PANELS Lipid Panel Test System",
        "PTS PANELS HDL Cholesterol Test System",
        "PTS PANELS CHOL+HDL Panel Test System",
        "PTS PANELS CHOL+HDL+GLU Panel Test System",
        "PTS PANELS Metabolic Chemistry Panel Test System"
    ],
    "Submitter Information": "Polymer Technology Systems, Inc.",
    "510(k) Number": "K142302",
    "Predicate Device Reference 510(k) Number(s)": [
        "K071507",
        "K070017"
    ],
    "Regulatory Class": "Class II, Class I",
    "Product Code(s)": [
        "CGA",
        "CHH",
        "JGY",
        "LBR",
        "MRR"
    ],
    "Summary Letter Date": "August 15, 2014",
    "Summary Letter Received Date": "August 18, 2014",
    "Submission Date": "September 26, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1175",
        "21 CFR 862.1705",
        "21 CFR 862.1475"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Cholesterol test system",
        "Triglyceride test system",
        "Lipoprotein test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose",
        "Cholesterol",
        "HDL Cholesterol",
        "Triglycerides"
    ],
    "Specimen Type(s)": [
        "Whole Blood",
        "Fingerstick Whole Blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BioScanner Plus (CardioChek PA) Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Reflectance photometry"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Test System",
        "Panel",
        "Test Strips",
        "Analyzer",
        "Strip"
    ],
    "Document Summary": "FDA 510(k) summary for BioScanner Plus Glucose and multiple PTS PANELS Test Systems for measuring glucose, cholesterol, HDL cholesterol, and triglycerides using reflectance photometry on CardioChek analyzer",
    "Indications for Use Summary": "Intended for quantitative determination of glucose, cholesterol, HDL cholesterol, and triglycerides in human whole blood or fingerstick whole blood by healthcare professionals or individuals with diabetes for the diagnosis and management of carbohydrate and lipid metabolism disorders",
    "fda_folder": "Clinical Chemistry"
}